Literature DB >> 3939747

Valproic acid in the treatment of Sydenham chorea.

L A Alvarez1, G Novak.   

Abstract

Severe cases of Sydenham chorea are still difficult to manage because optimal therapy has not been found. In this report severe chorea responded to valproic acid therapy after trials with diazepam and haloperidol had failed. The literature is reviewed and the possible mechanism of action of valproate in this movement disorder is discussed. Valproic acid is proposed as an effective treatment for severe cases of Sydenham chorea.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3939747     DOI: 10.1016/0887-8994(85)90037-2

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

1.  Sodium valproate in the treatment of Sydenham's chorea.

Authors:  Tapas K Sabui; Pragya Pant
Journal:  Indian J Pediatr       Date:  2010-06       Impact factor: 1.967

2.  An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions.

Authors:  Kathleen G Walker; Jo M Wilmshurst
Journal:  Ther Adv Neurol Disord       Date:  2010-09       Impact factor: 6.570

Review 3.  Treatment of Sydenham's Chorea: A Review of the Current Evidence.

Authors:  Shannon L Dean; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-06-01

Review 4.  Therapeutic aspects of Sydenham's Chorea: an update.

Authors:  Greta Depietri; Niccolo Carli; Attilio Sica; Domenico Oliviero; Giorgio Costagliola; Pasquale Striano; Alice Bonuccelli; Flavia Frisone; Diego Peroni; Rita Consolini; Thomas Foiadelli; Alessandro Orsini
Journal:  Acta Biomed       Date:  2022-03-21

5.  Sydenham Chorea in Children.

Authors:  Lori C. Jordan; Harvey S. Singer
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

Review 6.  Treatment of Secondary Chorea: A Review of the Current Literature.

Authors:  Erin Feinstein; Ruth Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.